Articles

Dr. L.H. Young and colleagues reported the lack ofutility of MPI for predicting myocardial events in the DIADstudy.1 However, the article contained information that suggestsa simpler and possibly more effective means of predicting cardiovascularevents.

Collaboration between doctors and pharmacists can reduce medication-related problems and hospitalizations and improve health outcomes in patients with heart failure.

In a recent published study, it was found that when insulin was the first treatment choice over multiple oral drugs, there was less weight gain and fewer hypoglycemic reactions. Give your patients a choice!  

Insulin resistance and impaired glucose tolerance developed in healthy volunteers after just two weeks of a shortened sleep schedule in a randomized crossover trial.  

The US Food and Drug Administration (FDA) has notified healthcare professionals of the potential for falsely elevated blood glucose results with the use of glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) glucose test strips in patients receiving products containing certain nonglucose sugars.  

Two new guides released last week by HHS’ Agency for Healthcare Research and Quality can help women with gestational diabetes and their doctors make informed decisions about different treatments for the condition.  

Excess urinary albumin excretion emerged as a significant predictor of mortality and other poor outcomes in a post analysis of about 2,300 heart-failure patients in a major clinical study.   

Cancer survivors who got radiation treatments as children have nearly twice the risk of developing diabetes as adults, say U.S. researchers. This correlation does not appear to be related to patients’ body mass index or physical inactivity.   

The Ras protein “drives cells crazy” and the anti-Ras drug being developed for the treatment of pancreatic cancer also shows that it is able to slow the progression of diabetes as well.

Researchers from North Carolina State University and Mayo Clinic have developed a computer model that medical doctors can use to determine the best time to begin using statin therapy in diabetes patients to help prevent heart disease and stroke.